Johan Hygum Dam

7PUBLICATIONS
23CO-AUTHORS
Cancer diagnosisMolecular targetsInstruments and techniquesCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 28, 2023
A randomised trial of [18F]PSMA-1007-PET/CT versus NaF-PET/CT for staging primary prostate cancer: A trial protocol.

Karen Middelbo Buch-Olsen, Mads Hvid Poulsen, Steinbjørn Hansen

|Oct 27, 2022
Preparation and Evaluation of [18F]AlF-NOTA-NOC for PET Imaging of Neuroendocrine Tumors: Comparison to [68Ga]Ga-DOTA/NOTA-NOC.

Johan Hygum Dam, Niels Langkjær, Christina Baun

|Jan 07, 2021
Multi-curie production of gallium-68 on a biomedical cyclotron and automated radiolabelling of PSMA-11 and DOTATATE.

Helge Thisgaard, Joel Kumlin, Niels Langkjær

|Dec 23, 2020
Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer.

Christina Baun, Bogdan Mitran, Sara S Rinne

|Nov 21, 2019
Selection of an optimal macrocyclic chelator improves the imaging of prostate cancer using cobalt-labeled GRPR antagonist RM26.

Bogdan Mitran, Helge Thisgaard, Sara Rinne

|Jul 22, 2017
The use of radiocobalt as a label improves imaging of EGFR using DOTA-conjugated Affibody molecule.

Javad Garousi, Ken G Andersson, Johan H Dam

Pageof 2

Frequent Collaborators

3 joint publications

Helge Thisgaard

2 joint publications

Christina Baun

2 joint publications

Birgitte Brinkmann Olsen

2 joint publications

Vladimir Tolmachev